Robeauté is turning microrobotics into a surgical platform for the brain

2026-01-02 · Source: Tech.eu - Tech.eu · Field: Health & Wellbeing — Medical Devices & Health Technology, Clinical Care & Medical Practice, Medical Specialties & Subspecialties · Depth: Intermediate, medium

Summary

Paris-based MedTech startup Robeauté is developing a new class of therapeutic microrobots designed to diagnose, treat, and monitor the brain from within. These microrobots, roughly the size of a grain of rice, can navigate non-linear paths through the brain's extracellular matrix to reach multiple sites. The modular device features a universal robotic core with interchangeable micro-extensions, enabling applications like targeted drug delivery, electrode implantation, and real-time data collection. Co-founder Joana Cartocci highlights that Robeauté's active device approach, with over 50 patents, offers superior control compared to passive, electromagnetically-driven academic microrobots. The company raised $28 million in January 2025 and plans first-in-human studies by the end of 2026, with the US as its initial market due to more collaborative regulatory processes.

Key takeaway

For MedTech investors evaluating disruptive neurosurgical platforms, Robeauté's active microrobotics approach, with its modularity and focus on precise control, represents a significant advancement over passive systems. Your due diligence should consider the company's strong patent portfolio and strategic US market entry plan, which leverages a more collaborative FDA regulatory pathway to accelerate clinical trials and commercialization, potentially setting a new standard for brain intervention.

Key insights

Robeauté's active microrobots offer precise, modular brain intervention, overcoming limitations of passive academic designs.

Principles

• Active microrobots provide superior control for neurosurgery.
• Modular design enables broad clinical applications.
• Regulatory strategy co-creation accelerates market entry.

Method

Robeauté's system uses a tiny, active carrier for non-linear navigation and continuous ultrasound tracking, combined with interchangeable extensions for specific medical tasks like biopsy or drug delivery.

In practice

• Target brain cancer diagnosis and treatment.
• Implant electrodes for neuropathologies.
• Collect live cellular data from deep brain.

Topics

• Microrobotics
• Medical Robotics
• Targeted Drug Delivery
• Robotic Navigation
• Biomedical Sensing

Best for: Investor, Entrepreneur, Robotics Engineer

Related on AIssential

• Leiden scientists 3D-print microrobots that “swim” without a brain — Microrobots can achieve complex navigation through physical design and environmental feedback, not just electronics.
• DeepMind handpicked this startup for its robotics accelerator. Now it’s raised an $11.7m seed round — DeepMind-backed Acumino scales industrial automation by deploying deep-learning robot models for dexterous tasks, emphasizing open, modular systems.
• Neura CEO on raising Europe’s biggest ever robotics round: ‘It’s not science fiction’ — Neura Robotics is democratizing advanced AI-powered "cognitive robotics" for widespread human-robot collaboration.
• LEM Surgical - Dynamis Robotic Surgical System — Humanoid surgical robots can enhance precision and reduce workload in complex procedures.
• Ads Just Hit ChatGPT — AI is rapidly integrating into daily life, from ad-supported models to advanced robotics and critical applications like surgery.
• A benchmarking framework for embodied neuromorphic agents — A new framework standardizes benchmarking for neuromorphic control of soft robots in dynamic, real-world environments.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Tech.eu - Tech.eu.